Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGILENT TECHNOLOGIES, INC.A · Entity 3062 | Sr Vice President | March 29, 2018 | March 29, 2018 |
| BECTON DICKINSON & COBDX · Entity 2498 | EVP & Pres Life Sciences | November 26, 2020 | November 30, 2020 |
| METTLER TOLEDO INTERNATIONAL INC/MTD · Entity 3168 | President and CEO | August 27, 2026 | August 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGILENT TECHNOLOGIES, INC.
Report date March 29, 2018 · Filed March 29, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,547.467 |
Ending reported balance
After 2018-03-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-03-29 · Exercise / conversion · Acquired 4,000 · Balance 72,547.467 Row 2 · 2018-03-29 · Sale · Disposed 4,000 · Balance 68,547.467 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.26 · Expires 2024-11-19 | Direct | 11,292 |
Reported balance
After 2018-03-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-29 · Exercise / conversion · Disposed 4,000 · Balance 11,292 F1: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3. F2: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.
F2: The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.
BECTON DICKINSON & CO
Report date November 26, 2020 · Filed November 30, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Rights to Common Stock Under BD Deferred Compensation PlanSEC Table II · derivative / convertible security | Direct | 621 |
Reported balance
After 2020-11-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-11-26 · Grant · Acquired 621 · Balance 621 F1: The securities convert to common stock on a one-for-one basis. F2: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities convert to common stock on a one-for-one basis.
F2: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person.
METTLER TOLEDO INTERNATIONAL INC/
Report date August 27, 2026 · Filed August 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 4,480 |
Ending reported balance
After 2026-08-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-27 · Exercise / conversion · Acquired 942 · Balance 5,422 Row 2 · 2026-08-27 · Sale · Disposed 942 · Balance 4,480 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1,024.55 · Expires 2033-11-09 | Direct | 4,413 |
Reported balance
After 2026-08-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-27 · Exercise / conversion · Disposed 942 · Balance 4,413 F1: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest annually in five equal installments beginning on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2026 Filed Aug 31, 2026 13:01 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | Exercise / conversionStock Option (right to buy) · Derivative | 942 | $0.00 Strike: $1,024.55 | $0.00 |
DisclosureSEC source: 0001037646-26-000065 · form4.xml · derivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,413 Underlying: Common Stock, par value $0.01 per share · 942 shares Expires 2033-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 13:01 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | SaleCommon Stock, par value $0.01 per share | 942 | $1,425.00 | $1,342,350.00 |
DisclosureSEC source: 0001037646-26-000065 · form4.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,480 Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 13:01 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | Exercise / conversionCommon Stock, par value $0.01 per share | 942 | $1,024.55 | $965,126.10 |
DisclosureSEC source: 0001037646-26-000065 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2026 Filed May 14, 2026 14:41 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 2,005 | $0.00 Strike: $1,072.45 | $0.00 |
DisclosureSEC source: 0001037646-26-000030 · form4.xml · derivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,005 Underlying: Common Stock, par value $0.01 per share · 2,005 shares Expires 2036-05-12 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| May 12, 2026 Filed May 14, 2026 14:41 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 810 | $0.00 | $0.00 |
DisclosureSEC source: 0001037646-26-000030 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,480 Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1,024.55 | $0.00 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · derivative · entry 8 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,355 Underlying: Common Stock, par value $0.01 per share · 2,000 shares Expires 2033-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | SaleCommon Stock, par value $0.01 per share | 925 | $1,463.88 | $1,354,089.00 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · nonDerivative · entry 6 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,670 F4 · price: Represents the average sales price of multiple individual transactions at prices between $1,463.62 and $1,464.02. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | SaleCommon Stock, par value $0.01 per share | 442 | $1,462.26 | $646,318.92 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · nonDerivative · entry 5 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 F3 · price: Represents the average sales price of multiple individual transactions at prices between $1,462.25 and $1,462.28. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | SaleCommon Stock, par value $0.01 per share | 50 | $1,461.20 | $73,060.00 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · nonDerivative · entry 4 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,037 F2 · price: Represents the average sales price of multiple individual transactions at prices between $1,461.00 and $1,461.53. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | SaleCommon Stock, par value $0.01 per share | 583 | $1,460.60 | $851,529.80 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · nonDerivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,087 F1 · price: Represents the average sales price of multiple individual transactions at prices between $1,459.74 and $1,460.65. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | Exercise / conversionCommon Stock, par value $0.01 per share | 2,000 | $1,024.55 | $2,049,100.00 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 1,495 | $0.00 Strike: $1,445.06 | $0.00 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · derivative · entry 7 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,495 Underlying: Common Stock, par value $0.01 per share · 1,495 shares Expires 2035-11-11 F5 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 16:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001037646-25-000098 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,670 Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 16:46 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001037646-25-000066 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,094 F1 · date: Represents the number of shares earned in respect of the three-year performance period that was certified on November 7, 2025, which shares will be delivered upon vesting in January 2026. Read SEC document |
| May 08, 2025 Filed May 12, 2025 21:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 1,855 | $0.00 Strike: $1,101.63 | $0.00 |
DisclosureSEC source: 0001062993-25-009114 · form4.xml · derivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,855 Underlying: Common Stock, par value $0.01 per share · 1,855 shares Expires 2035-05-08 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| May 08, 2025 Filed May 12, 2025 21:10 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009114 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,091 Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 18:26 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 6,175 | $0.00 Strike: $1,260.97 | $0.00 |
DisclosureSEC source: 0001062993-24-019097 · form4.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,175 Underlying: Common Stock, par value $0.01 per share · 6,175 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 14:18 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 7,355 | $0.00 Strike: $1,024.55 | $0.00 |
DisclosureSEC source: 0001062993-23-020552 · form4.xml · derivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,355 Underlying: Common Stock, par value $0.01 per share · 7,355 shares Expires 2033-11-09 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 14:18 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 976 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-020552 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,363 Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 15:46 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 6,315 | $0.00 Strike: $1,225.87 | $0.00 |
DisclosureSEC source: 0001062993-22-021607 · form4.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Common Stock, par value $0.01 per share · 6,315 shares Expires 2032-11-03 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:39 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 121 | $1,319.45 | $159,653.45 |
DisclosureSEC source: 0001062993-22-008045 · form4.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,387 Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 14:58 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 6,585 | $0.00 Strike: $1,484.40 | $0.00 |
DisclosureSEC source: 0001062993-21-010360 · form4.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,585 Underlying: Common Stock, par value $0.01 per share · 6,585 shares Expires 2031-11-04 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:55 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 4,810 | $0.00 Strike: $1,175.19 | $0.00 |
DisclosureSEC source: 0001515622-21-000018 · edgar.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,810 Underlying: Common Stock, par value $0.01 per share · 4,810 shares Expires 2031-04-01 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 14:44 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | PurchaseCommon Stock, par value $0.01 per share | 50 | $1,170.00 | $58,500.00 |
DisclosureSEC source: 0001515622-21-000014 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,266 Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 15:50 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantStock Option (right to buy) · Derivative | 4,615 | $0.00 Strike: $1,233.47 | $0.00 |
DisclosureSEC source: 0001515622-21-000003 · edgar.xml · derivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,615 Underlying: Common stock, par value $0.01 per share · 4,615 shares Expires 2031-01-25 F1 · derivative.exercise_date: The options vest annually in five equal installments beginning on the first anniversary of the date of grant. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 15:50 UTC | METTLER TOLEDO INTERNATIONAL INC/ MTD · Entity 3168 | GrantCommon Stock, par value $0.01 per share | 1,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001515622-21-000003 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · CEO Designate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,216 Read SEC document |
| November 26, 2020 Filed Nov 30, 2020 20:45 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 621 | $227.47 | $141,258.87 |
DisclosureSEC source: 0001543407-20-000048 · edgar.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621 Underlying: Common Stock · 621 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 17:31 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 620 | $263.40 | $163,308.00 |
DisclosureSEC source: 0001543407-20-000038 · edgar.xml · derivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620 Underlying: Common Stock · 620 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 13:31 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,272 | $260.00 | $330,720.00 |
DisclosureSEC source: 0001543407-20-000037 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,340 F1 · price: This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019. Read SEC document |
| June 05, 2020 Filed Jun 5, 2020 19:07 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,049 | $243.20 | $255,116.80 |
DisclosureSEC source: 0001543407-20-000036 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,612 F2 · price: This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 19:07 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 2,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000036 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,661 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| June 02, 2020 Filed Jun 2, 2020 18:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 222 | $244.83 | $54,352.26 |
DisclosureSEC source: 0001543407-20-000035 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,688 F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $244.83 through $244.91. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 18:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-20-000035 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,910 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 4,236 | $0.00 Strike: $242.10 | $0.00 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · derivative · entry 4 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,710 Underlying: Common Stock · 4,236 shares Expires 2028-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2019. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 339 | $263.23 | $89,234.97 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · nonDerivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,310 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.19 through $263.24. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 3,897 | $263.23 | $1,025,807.31 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,649 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.19 through $263.24. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 14:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 4,236 | $242.10 | $1,025,535.60 |
DisclosureSEC source: 0001543407-19-000073 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2019 Filed Dec 6, 2019 21:11 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 312 | $261.51 | $81,591.12 |
DisclosureSEC source: 0001543407-19-000068 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,310 Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:27 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 18,119 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000064 · edgar.xml · derivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,119 Underlying: Common Stock · 18,119 shares Expires 2029-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:27 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000064 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,622 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 13:57 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 127 | $253.78 | $32,230.06 |
DisclosureSEC source: 0001543407-19-000043 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,930 Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 15:11 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 2,865 | $0.00 Strike: $224.94 | $0.00 |
DisclosureSEC source: 0001543407-19-000042 · edgar.xml · derivative · entry 5 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,193 Underlying: Common Stock · 2,865 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning June 1, 2019. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 15:11 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 150 | $246.53 | $36,979.50 |
DisclosureSEC source: 0001543407-19-000042 · edgar.xml · nonDerivative · entry 4 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,057 Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 15:11 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 250 | $246.56 | $61,640.00 |
DisclosureSEC source: 0001543407-19-000042 · edgar.xml · nonDerivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,207 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $246.53 through $246.86. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 15:11 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 2,615 | $246.56 | $644,754.40 |
DisclosureSEC source: 0001543407-19-000042 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,457 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $246.53 through $246.86. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 15:11 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 2,865 | $224.94 | $644,453.10 |
DisclosureSEC source: 0001543407-19-000042 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 13:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 2,865 | $0.00 Strike: $224.94 | $0.00 |
DisclosureSEC source: 0001543407-19-000035 · edgar.xml · derivative · entry 4 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,058 Underlying: Common Stock · 2,865 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning June 1, 2019. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 13:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 191 | $241.03 | $46,036.73 |
DisclosureSEC source: 0001543407-19-000035 · edgar.xml · nonDerivative · entry 3 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,207 Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 13:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 2,674 | $241.03 | $644,514.22 |
DisclosureSEC source: 0001543407-19-000035 · edgar.xml · nonDerivative · entry 2 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,398 Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 13:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 2,865 | $224.94 | $644,453.10 |
DisclosureSEC source: 0001543407-19-000035 · edgar.xml · nonDerivative · entry 1 Kaltenbach Patrick · CIK 0001625775 · EVP & Pres Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.